David P. Luci's Insider Trades & SAST Disclosures
David P. Luci's most recent trade in Acurx Pharmaceuticals Inc was a trade of 250,000 Stock Option done . Disclosure was reported to the exchange on Feb. 5, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern David P. Luci.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acurx Pharmaceuticals Inc | David P. Luci | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 250,000 | 250,000 | - | - | Stock Option | |
| Acurx Pharmaceuticals Inc | David P. Luci | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 06 Jan 2025 | 49,261 | 49,261 | - | - | Warrants for Common Stock | |
| Acurx Pharmaceuticals Inc | David P. Luci | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 06 Jan 2025 | 49,261 | 1,097,458 | - | 1.0 | 50,000 | Common Stock |
| Acurx Pharmaceuticals Inc | David P. Luci | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 250,000 | 250,000 | - | - | Stock Option | |
| Acurx Pharmaceuticals Inc | Luci P. David | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2024 | 19,737 | 0 | - | - | Warrants for Common Stock | |
| Acurx Pharmaceuticals Inc | P. David Luci | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.55 per share. | 03 Jan 2024 | 19,737 | 1,048,197 | - | 3.5 | 70,066 | Common Stock |
| Acurx Pharmaceuticals Inc | David P. Luci | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.80 per share. | 19 Nov 2021 | 5,200 | 1,008,723 | - | 4.8 | 24,960 | Common Stock |
| Acurx Pharmaceuticals Inc | David P. Luci | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 500,000 | 500,000 | - | - | Stock Option | |
| Acurx Pharmaceuticals Inc | David P. Luci | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 350,000 | 350,000 | - | - | Stock Option |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges